ATP stimulates the proliferation of MCF-7 cells through the PI3K/Akt signaling pathway

Archives of Biochemistry and Biophysics

Volumn 499, Issue 1-2, 2010, Pages 40-48

  Bilbao, Paola Scodelaro ^a   Santillán, Graciela ^a   Boland, Ricardo ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

ATP; MCF 7 cells; PI3K Akt; PKC; Proliferation; Src

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE BETA S; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ADENOSINE TRIPHOSPHATE GAMMA S; ANTISENSE OLIGONUCLEOTIDE; CALCIUM ION; EGTAZIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; NUCLEOTIDE; PURINERGIC P2 RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BREAST TUMOR; CALCIUM SIGNALING; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; ONCOGENE SRC; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; BASE SEQUENCE; BREAST NEOPLASMS; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENES, SRC; HUMANS; MAP KINASE SIGNALING SYSTEM; NUCLEOTIDES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 77953699065     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2010.05.001     Document Type: Article

References (62)

1. Abbracchio M.P., Burnstock G. Jpn. J. Pharmacol. 1998, 78:113-145.
2. von Kugelgen I. Pharmacol. Ther. 2006, 110:415-432.
3. White N., Burnstock G. Trends Pharmacol. Sci. 2006, 27:211-217.
4. Erb L., Liao Z., Seye C.I., Weisman G.A. Eur. J. Physiol. 2006, 452:552-562.
5. Katz S., Boland R., Santillán G. Int. J. Biochem. Cell Biol. 2006, 38:2082-2091.
6. Scodelaro Bilbao P., Boland R., Russo de Boland A., Santillán G. Arch. Biochem. Biophys. 2007, 466:15-23.
7. Wagsatff S.C., Bowler W.B., Gallagher J.A., Hipskind R.A. Carcinogen 2000, 21:2175-2181.
8. Montiel M., de la Blanca E.P., Jiménez E. Cell. Physiol. Biochem. 2006, 18:123-134.
9. González L., Agulló-Ortuño M.T., García-Martínez J.M., Calabrini A., Gamallo C., Palacios J., Aranda A., Martín-Pérez J. J. Biol. Chem. 2006, 281:20851-20864.
10. Hiscox S., Morgan L., Green T., Nicholson R.I. Endocr.-Relat. Cancer 2006, 13:S53-S59.
11. Hanada M., Feng J., Hemmings B.A. Biochem. Biophys. Acta 2004, 1697:3-16.
12. Fresno Vara J.A., Casado E., de Castro J., Cejas P., Belda-Iniesta C., González-Barón M. Cancer Treat. Rev. 2004, 30:193-204.
13. Song Y.H., Godard M., Li Y., Richmond S.R., Rosenthal N., Delafontaine P. J. Invest. Med. 2005, 53:135-142.
14. Brazil D.P., Hemmings B.A. Trends Biochem. Sci. 2001, 26:657-664.
15. Krasilnikov M.A. Biochemistry (Mosc) 2000, 65:59-67.
16. Kumar A., Carrera A.C. Cell Cycle 2007, 6:1696-1698.
17. Liu W., Bagaitkar J., Watabe K. Front Biosci. 2007, 12:4011-4019.
18. Gerasimovskaya E.V., Tucker D.A., Weiser-Evans M., Wenzlau J.M., Klemm D.J., Banks M., Stenmark K.R. J. Biol. Chem. 2005, 280:1838-1848.
19. Heo J.S., Han H.J. Stem Cells 2006, 24:2637-2648.
20. Huwiler A., Roèlz W., Dorsch S., Ren S., Pfeilschifter J., Huwiler J. Br. J. Pharmacol. 2002, 136:520-529.
21. Bradford M. Anal. Biochem. 1976, 72:248-254.
22. Laemmli U.K. Nature 1970, 227:680-685.
23. Park S., Mazina O., Kitagawa A., Wong P., Matsumura F. J. Biochem. Mol. Toxicol. 2004, 18:322-331.
24. Chan T.O., Tsichilis P.N. Sci. 2001 2001, PE1.
25. Módis K., Gero D., Nagy N., Szoleczky P., Tóth Z.D., Szabó C. Br. J. Pharmacol. 2009, 158:1565-1578.
26. Blanco-Aparicio C., Renner O., Leal J.F., Carnero A. Carcinogen 2007, 28:1379-1386.
27. Chung H., Seo S., Moon M., Park S. J. Endocrinol. 2008, 198:511-521.
28. Jacques-Silva M.C., Rodnight R., Lenz G., Liao Z., Kong Q., Tran M., Kang Y., Gonzalez F.A., Weisman G.A., Neary J.T. Br. J. Pharmacol. 2004, 141:1106-1117.
29. Kidd L.B., Schabbauer G.A., Luyendyk J.P., Holscher T.D., Tilley R.E., Tencati M., Mackman N.J. Pharmacol. Exp. Ther. 2008, 326:348-353.
30. van Kolen K., Slegers H. Purinergic Signal. 2006, 2:451-469.
31. Maruyama T., Kanaji T., Nakade S., Kanno T., Mikoshiba K. J. Biochem. 1997, 122:498-505.
32. Gliki G., Wheeler-Jones C., Zachary I. Cell Biol. Int. 2002, 26:751-759.
33. Bauer B., Jenny M., Fresser F., Uberall F., Baier G. FEBS Lett. 2003, 541:155-162.
34. Salamanca D.A., Khalil R.A. Biochem. Pharmacol. 2005, 70:1537-1547.
35. Scodelaro Bilbao P., Boland R., Santillán G. Arch. Biochem. Biophys. 2010, 494:7-14.
36. Go Y.M., Park H., Maland M.C., Darley-Usmar V.M., Stoyanov B., Wetzker R., Jo H. Am. J. Physiol. 1998, 275:H1898-H1904.
37. Montiel M., de la Blanca E.P., Jiménez E. Cell. Physiol. Biochem. 2006, 18:123-134.
38. Abbracchio M.P., Ceruti S. Purinergic Signal. 2006, 2:595-604.
39. Neary J.T., Kang Y., Shi Y.F. Neurochem. Res. 2004, 29:2037-2042.
40. Liang K., Jin W., Knuefermann C., Schmidt M., Mills G.B., Ang K.K., Milas L., Fan Z. Mol. Cancer Ther. 2003, 2:353-360.
41. Katz S., Boland R., Santillán G. Arch. Biochem. Biophys. 2008, 477:244-252.
42. Ralevic V., Burnstock G. Pharmacol. Rev. 1998, 50:413-492.
43. Rotenberg S.A., Huang M.H., Zhu J., Su L., Riedel H. Mol. Carcinogen 1995, 12:42-49.
44. Sun M., Yang L., Feldman R.I., Sun X.M., Bhalla K.N., Jove R., Nicosia S.V., Cheng J.Q. J. Biol. Chem. 2003, 278:42992-43000.
45. Gates A., Hohenester S., Anwer M.S., Webster C.R. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G764-G774.
46. Thamilselvan V., Craig D.H., Basson M.D. FASEB J. 2007, 21:1730-1741.
47. Turjanski A.G., Vaque J.P., Gutkind J.S. Oncogene 2007, 26:3240-3253.
48. Muscella A., Greco S., Elia M.G., Storelli C., Marsigliante S. J. Cell. Physiol. 2004, 200:428-439.
49. Santiago-Pérez L.I., Flores R.V., Santos-Berríos C., Chorna N.E., Krugh B., Garrad R.C., Erb L., Weisman G.A., González F.A. J. Cell. Physiol. 2001, 187:196-208.
50. Dixon C.J., Bowler W.B., Fleetwood P., Ginty A.F., Gallagher J.A., Carron J.A. Br. J. Cancer 1997, 75:34-39.
51. Potucek I.D., Crain J.M., Watters J.J. Neurochem. Int. 2006, 49:204-214.
52. Nandigama R., Padmasekar M., Wartenberg M., Saber H. J. Biol. Chem. 2006, 281:5686-5693.
53. Mancino G., Placido R., Di Virgilio F. J. Biol. Regulat. Homeost. Agents 2001, 15:286-293.
54. Sellers L.A., Simon J., Lundahl T.S., Cousens D.J., Humphrey P.P.A., Barnard E.A. J. Biol. Chem. 2001, 276:16379-16390.
55. Coutinho-Silva R., Stahl L., Cheung K.-K., Enes de Campos N., Oliveira Souza C., Ojcius D.M., Burnstock G. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G1024-G1035.
56. Harada H., Chan C.M., Loesch A., Unwin R., Burnstock G. Kidney Int. 2000, 57:949-958.
57. Harper S., Webb T.E., Charlton S.J., Ng L.L., Boarder M.R. Br. J. Pharmacol. 1998, 124:703-710.
58. Lazarowski E.R., Harden T.K. Br. J. Pharmacol. 1999, 127:1272-1278.
59. Mirza A.M., Gysin S., Malek N., Nakayama K., Roberts J.M., McMahon M. Mol. Cell. Biol. 2004, 24:10868-10881.
60. Krymskaya V.P., Penn R.B., Orsini M.J., Scott P.H., Plevin R.J., Walker T.R., Eszterhas A.J., Amrani Y., Chilvers E.R., Panettieri R.A. Am. J. Physiol. 1999, 277:L65-L78.
61. Kuemmerle J.F., Bushman T.L. Am. J. Physiol. 1998, 275:G151-G158.
62. Tokunaga E., Oki E., Egashira A., Sadanaga N., Morita M., Kakeji Y., Maehara Y. Curr. Cancer Drug Targets 2008, 8:27-36.